Loss of p53 induces epidermal growth factor receptor promoter activity in normal human keratinocytes

Oncogene

Volumn 27, Issue 31, 2008, Pages 4315-4323

  Bheda, A ^a   Creek, K E ^a   Pirisi, L ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

EGFR promoter; HPV16; Human keratinocytes; p53; Sp1; YY1

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR YY1;

ARTICLE; BINDING SITE; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; MUTATIONAL ANALYSIS; NEWBORN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BINDING SITES; CELL LINE, TUMOR; CELL NUCLEUS; GENE EXPRESSION REGULATION; HUMAN PAPILLOMAVIRUS 16; HUMANS; KERATINOCYTES; MUTAGENESIS, SITE-DIRECTED; MUTATION; PROMOTER REGIONS (GENETICS); RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; SP1 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN P53; YY1 TRANSCRIPTION FACTOR;

HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 47549117378     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.65     Document Type: Article

References (32)

1. Ai W, Narahari J, Roman A. (2000). Yin yang 1 negatively regulates the differentiation-specific E1 promoter of human papillomavirus type 6. J Virol 74: 5198-5205.
2. Akerman GS, Tolleson WH, Brown KL, Zyzak LL, Mourateva E, Engin TS et al. (2001). Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes. Cancer Res 61: 3837-3843.
3. Arteaga CL. (2002). Epidermal growth factor receptor dependence in human tumors: more than just expression? Oncologist 7(Suppl 4): 31-39.
4. Baldwin A, Pirisi L, Creek KE. (2004). NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression. J Virol 78: 3953-3964.
5. Deb SP, Munoz RM, Brown DR, Subler MA, Deb S. (1994). Wild-type human p53 activates the human epidermal growth factor receptor promoter. Oncogene 9: 1341-1349.
6. Dykxhoorn DM, Lieberman J. (2005). The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Annu Rev Med 56: 401-423.
7. Gordon S, Akopyan G, Garban H, Bonavida B. (2006). Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 25: 1125-1142.
8. Gronroos E, Terentiev AA, Punga T, Ericsson J. (2004). YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. Proc Natl Acad Sci USA 101: 12165-12170.
9. Haley J, Whittle N, Bennet P, Kinchington D, Ullrich A, Waterfield M. (1987). The human EGF receptor gene: structure of the 110 kb locus and identification of sequences regulating its transcription. Oncogene Res 1: 375-396.
10. Hu G, Liu W, Mendelsohn J, Ellis LM, Radinsky R, Andreeff M et al. (1997). Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells. J Natl Cancer Inst 89: 1271-1276.
11. Innocente SA, Lee JM. (2005). p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription. FEBS Lett 579: 1001-1007.
12. Ishii S, Xu YH, Stratton RH, Roe BA, Merlino GT, Pastan I. (1985). Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene. Proc Natl Acad Sci USA 82: 4920-4924.
13. Johnson AC, Murphy BA, Matelis CM, Rubinstein Y, Piebenga EC, Akers LM et al. (2000). Activator protein-1 mediates induced but not basal epidermal growth factor receptor gene expression. Mol Med 6: 17-27.
14. Kageyama R, Merlino GT, Pastan I. (1988). Epidermal growth factor (EGF) receptor gene transcription. Requirement for Sp1 and an EGF receptor-specific factor. J Biol Chem 263: 6329-6336.
15. Kawada H, Nishiyama C, Takagi A, Tokura T, Nakano N, Maeda K et al. (2005). Transcriptional regulation of ATP2C1 gene by Sp1 and YY1 and reduced function of its promoter in Hailey-Hailey disease keratinocytes. J Invest Dermatol 124: 1206-1214.
16. Kilic G, Cardillo M, Ozdemirli M, Arun B. (1999). Human papillomavirus 18 oncoproteins E6 and E7 enhance irradiation- and chemotherapeutic agent-induced apoptosis in p53 and Rb mutated cervical cancer cell lines. Eur J Gynaecol Oncol 20: 167-171.
17. Lee JS, Galvin KM, Shi Y. (1993). Evidence for physical interaction between the zinc-finger transcription factors YY1 and Sp1. Proc Natl Acad Sci USA 90: 6145-6149.
18. Ludes-Meyers JH, Subler MA, Shivakumar CV, Munoz RM, Jiang P, Bigger JE et al. (1996). Transcriptional activation of the human epidermal growth factor receptor promoter by human p53. Mol Cell Biol 16: 6009-6019.
19. Mathur SP, Mathur RS, Rust PF, Young RC. (2001). Human papilloma virus (HPV)-E6/E7 and epidermal growth factor receptor (EGF-R) protein levels in cervical cancer and cervical intraepithelial neoplasia (CIN). Am J Reprod Immunol 46: 280-287.
20. Pirisi L, Creek KE, Doniger J, DiPaolo JA. (1988). Continuous cell lines with altered growth and differentiation properties originate after transfection of human keratinocytes with human papillomavirus type 16 DNA. Carcinogenesis 9: 1573-1579.
21. Pirisi L, Yasumoto S, Feller M, Doniger J, DiPaolo JA. (1987). Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol 61: 1061-1066.
22. Sheikh MS, Carrier F, Johnson AC, Ogdon SE, Fornace Jr AJ. (1997). Identification of an additional p53-responsive site in the human epidermal growth factor receptor gene promoter. Oncogene 15: 1095-1101.
23. Shi Y, Lee JS, Galvin KM. (1997). Everything you have ever wanted to know about Yin Yang 1. Biochim Biophys Acta 1332: F49-F66.
24. Sui G, Affar el B, Shi Y, Brignone C, Wall NR, Yin P et al. (2004). Yin Yang 1 is a negative regulator of p53. Cell 117: 859-872.
25. Wang X, Bolotin D, Chu DH, Polak L, Williams T, Fuchs E. (2006). AP-2alpha: a regulator of EGF receptor signaling and proliferation in skin epidermis. J Cell Biol 172: 409-421.
26. Xu J, Thompson KL, Shephard LB, Hudson LG, Gill GN. (1993). T3 receptor suppression of Sp1-dependent transcription from the epidermal growth factor receptor promoter via overlapping DNA-binding sites. J Biol Chem 268: 16065-16073.
27. Yakovleva T, Kolesnikova L, Vukojevic V, Gileva I, Tan-No K, Austen M et al. (2004). YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription. Biochem Biophys Res Commun 318: 615-624.
28. Yao YL, Yang WM, Seto E. (2001). Regulation of transcription factor YY1 by acetylation and deacetylation. Mol Cell Biol 21: 5979-5991.
29. Yarden Y, Sliwkowski MX. (2001). Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2: 127-137.
30. Yu J, Zhang L, Hwang PM, Rago C, Kinzler KW, Vogelstein B. (1999). Identification and classification of p53-regulated genes. Proc Natl Acad Sci USA 96: 14517-14522.
31. Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH et al. (2000). Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev 14: 981-993.
32. Zyzak LL, MacDonald LM, Batova A, Forand R, Creek KE, Pirisi L. (1994). Increased levels and constitutive tyrosine phosphorylation of the epidermal growth factor receptor contribute to autonomous growth of human papillomavirus type 16 immortalized human keratinocytes. Cell Growth Differ 5: 537-547.